Merck KGaA (MRK) – Research Analysts’ Recent Ratings Changes

A number of research firms have changed their ratings and price targets for Merck KGaA (FRA: MRK):

  • 12/13/2017 – Merck KGaA was given a new €115.00 ($136.90) price target on by analysts at Warburg Research. They now have a “buy” rating on the stock.
  • 12/12/2017 – Merck KGaA was given a new €100.00 ($119.05) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock.
  • 12/8/2017 – Merck KGaA was given a new €98.00 ($116.67) price target on by analysts at Nord/LB. They now have a “neutral” rating on the stock.
  • 12/6/2017 – Merck KGaA was given a new €120.00 ($142.86) price target on by analysts at UBS Group AG. They now have a “buy” rating on the stock.
  • 12/6/2017 – Merck KGaA was given a new €95.00 ($113.10) price target on by analysts at Bank of America Corp. They now have a “neutral” rating on the stock.
  • 12/1/2017 – Merck KGaA was given a new €98.00 ($116.67) price target on by analysts at Morgan Stanley. They now have a “neutral” rating on the stock.
  • 11/29/2017 – Merck KGaA was given a new €115.00 ($136.90) price target on by analysts at Warburg Research. They now have a “buy” rating on the stock.
  • 11/29/2017 – Merck KGaA was given a new €100.00 ($119.05) price target on by analysts at Goldman Sachs Group Inc. They now have a “neutral” rating on the stock.
  • 11/29/2017 – Merck KGaA was given a new €115.00 ($136.90) price target on by analysts at Sanford C. Bernstein. They now have a “buy” rating on the stock.
  • 11/28/2017 – Merck KGaA had its “neutral” rating reaffirmed by analysts at JPMorgan Chase & Co..
  • 11/23/2017 – Merck KGaA was given a new €116.00 ($138.10) price target on by analysts at Berenberg Bank. They now have a “buy” rating on the stock.
  • 11/20/2017 – Merck KGaA was given a new €100.00 ($119.05) price target on by analysts at Goldman Sachs Group Inc. They now have a “neutral” rating on the stock.
  • 11/15/2017 – Merck KGaA was given a new €115.00 ($136.90) price target on by analysts at Sanford C. Bernstein. They now have a “buy” rating on the stock.
  • 11/14/2017 – Merck KGaA had its “neutral” rating reaffirmed by analysts at DZ Bank AG.
  • 11/10/2017 – Merck KGaA was given a new €101.00 ($120.24) price target on by analysts at Societe Generale. They now have a “neutral” rating on the stock.
  • 11/10/2017 – Merck KGaA was given a new €125.00 ($148.81) price target on by analysts at Oddo Bhf. They now have a “buy” rating on the stock.
  • 11/10/2017 – Merck KGaA was given a new €99.00 ($117.86) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 11/9/2017 – Merck KGaA was given a new €98.00 ($116.67) price target on by analysts at Nord/LB. They now have a “neutral” rating on the stock.
  • 11/9/2017 – Merck KGaA was given a new €110.00 ($130.95) price target on by analysts at S&P Global. They now have a “buy” rating on the stock.
  • 11/9/2017 – Merck KGaA was given a new €120.00 ($142.86) price target on by analysts at UBS Group AG. They now have a “buy” rating on the stock.
  • 11/9/2017 – Merck KGaA was given a new €103.00 ($122.62) price target on by analysts at Independent Research GmbH. They now have a “neutral” rating on the stock.
  • 11/9/2017 – Merck KGaA was given a new €115.00 ($136.90) price target on by analysts at Warburg Research. They now have a “buy” rating on the stock.
  • 11/9/2017 – Merck KGaA was given a new €103.00 ($122.62) price target on by analysts at Commerzbank Ag. They now have a “neutral” rating on the stock.
  • 11/9/2017 – Merck KGaA was given a new €116.00 ($138.10) price target on by analysts at Berenberg Bank. They now have a “buy” rating on the stock.
  • 11/8/2017 – Merck KGaA was given a new €100.00 ($119.05) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock.
  • 11/6/2017 – Merck KGaA was given a new €115.00 ($136.90) price target on by analysts at Kepler Capital Markets. They now have a “buy” rating on the stock.
  • 11/3/2017 – Merck KGaA was given a new €112.00 ($133.33) price target on by analysts at equinet AG. They now have a “buy” rating on the stock.
  • 11/1/2017 – Merck KGaA was given a new €100.00 ($119.05) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock.
  • 10/27/2017 – Merck KGaA was given a new €125.00 ($148.81) price target on by analysts at Oddo Bhf. They now have a “buy” rating on the stock.

Merck KGaA (MRK) remained flat at $€90.28 ($107.48) during midday trading on Tuesday. Merck KGaA has a 52 week low of €87.33 ($103.96) and a 52 week high of €115.00 ($136.90). The stock has a market capitalization of $11,580.00 and a price-to-earnings ratio of 21.14.

MERCK Kommanditgesellschaft auf Aktien provides products in the healthcare, life science, and performance materials sectors worldwide. The company offers prescription medicines to treat colorectal cancer, head and neck tumors, multiple sclerosis, infertility, growth hormone disorders, cardiovascular disorders, diabetes, and thyroid disorders; diagnostics and prescription drugs for allergen immunotherapy; and biosimilars for oncology and inflammatory disorders.

What are top analysts saying about Merck KGaA? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Merck KGaA and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit